Eli Lilly and Company (LLY), based in Indianapolis, Indiana, with a market capitalization of approximately $1.1 trillion, is a global pharmaceutical company that researches, develops, manufactures, and markets medicines. Its treatments address conditions including diabetes, obesity, cancer, Alzheimer's disease, autoimmune disorders, migraines, and other health conditions worldwide.
LLY is set to report its Q3 earnings on Thursday, October 29, 2026, before the market opens. Wall Street anticipates diluted EPS of $7.54, a 7.4% increase from $7.02 in the same quarter last year. Notably, the company has topped analysts’ EPS expectations in each of the past four quarters.